Joshua Reed

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Lexington, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Junlin Ho, attorney-in-fact for Joshua Reed
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Joshua Reed

Form 4 holding Chief Financial Officer

Aldeyra Therapeutics, Inc.

Security class
Common Stock
Shares / value
274,825
Estimated value
$478,196
Report date
30 Mar 2022
Price
$1.74
Ownership
Direct
Form 4 holding Chief Financial Officer

Aldeyra Therapeutics, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
250,000
Estimated value
Report date
30 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Omega Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
110,000
Estimated value
Report date
07 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP, Chief Financial Officer

Alkermes plc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
66,430
Estimated value
Report date
02 Mar 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding SVP, Chief Financial Officer

Alkermes plc.

Security class
Restricted Stock Unit Award
Shares / value
30,854
Estimated value
Report date
02 Mar 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Joshua Reed

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .